Capital Investment Advisors LLC boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 5.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 305,468 shares of the biopharmaceutical company’s stock after acquiring an additional 16,050 shares during […]
Gilead Sciences, Inc (NASDAQ:GILD) Stock Holdings Cut by Arrowstreet Capital Limited Partnership themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Caisse DE Depot ET Placement DU Quebec increased its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 3.2% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,130,699 shares of the biopharmaceutical company’s stock after buying an […]
Stamos Capital Partners L.P. grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 17.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 37,420 shares of the biopharmaceutical company’s stock after purchasing an additional 5,670 shares during the […]
Best Buy (NYSE:BBY – Free Report) had its price target decreased by UBS Group from $87.00 to $85.00 in a research report released on Wednesday, MarketBeat reports. UBS Group currently has a buy rating on the technology retailer’s stock. Several other equities analysts have also issued reports on BBY. DA Davidson dropped their price target […]